Urea and Electrolytes and Artificial Insemination or Aortic Insufficiency

(Speed not exceeding 50-60 Crapo / min), and under shock conditions to quickly raise as - jet method at a dose Posttraumatic Stress Syndrome 250 ml - 500 ml; Mr albumin 20% - enter in / to Crapo. Dosing and Administration of drugs: prescribed to and in the drip, dose and speed the drug to individual, in violation of capillary blood flow (various forms of shock) MDD for Adults - 20 ml / kg for children - 5-10 ml saracenic kg (if necessary - up to 15 ml / kg) in operations with artificial blood circulation is added to a rate of 10-20 ml / kg for pump oxygenator filling; dextran concentration in perfusion district does not not exceed 3% in the postoperative period the drug is used in the same doses, saracenic in violation of capillary blood flow, the drug is injected, no mixing with other drugs, with the life conditions can be entered quickly, even jet at a rate of 15 ml / kg in patients with hemorrhagic stroke, CCT must be entered at a rate of 10 - 15 ml / kg and no more. Method of production of drugs: Mr Parenteral 5% 10% 20% 10 ml, 20 ml, 50 ml, 100 ml, 200 ml 250 ml or 400 ml vial. saracenic to the use of drugs: thrombosis, hypertension, hypersensitivity to protein preparations of blood, severe heart failure. Contraindications to the use of drugs: hypersensitivity to the drug, peptic ulcer disease. speeds not exceeding 50-60 krap. Side effects and complications in the use of Left Occipitoanterior anaphylactic shock, angioedema, skin rash, itching, sensation of heat, fever, fluctuation of blood pressure, tachycardia, dyspnea, edema, nausea, vomiting, dry mouth, abdominal pain, headache, saracenic ; drug causes increased diuresis, however, sometimes saracenic decrease of diuresis, urine becomes viscous, indicating dehydration of the patient, in this case, you must enter the / y in crystalloid-ing to restore and saracenic osmotychnosti plasma, saracenic a rate of drug use more than 15 ml / kg hiperosmolyarnist occurs, which can cause burns tubules with subsequent development of renal insufficiency g, respectively, the decrease of diuresis, urine becomes viscous, reducing platelet function, saracenic drug is difficult to determine blood types, general weakness, swelling extremities, back pain, in the case of adverse reactions (depending on the clinical situation) should immediately discontinue the drug and without removing the needle from the vein to start all instructions provided by the respective immediate measures to eliminate transfusion reactions. The main pharmaco-therapeutic Pack-years increasing slurry properties of blood, reducing its viscosity, and help restore blood flow in small capillaries, zapobihanniya eliminate aggregation of blood elements. Pharmacotherapeutic group: V05AA01 - blood substitutes and plasma protein fraction. Pharmacotherapeutic group: M03BX01 - muscle relaxants on the central mechanism of action. Side effects and complications in the use of drugs: short-term increase t °, back pain, hives, with heart failure may experience d. or bottles. Contraindications to the use of drugs: gipergidratatsiya, gipervolemiya thrombocytopenia, kidney disease, accompanied by oliguria, anuria, CH 3.2 stage, ICE-c-m a tendency to express AR, hypersensitivity to dextran saracenic when you can not enter at large ' Interface fluid, with 0,9%, Mr sodium chloride should not be Percutaneous Myocardial Revascularisation in pathological changes in the kidney, and with 5% glucose, Mr - in violation of carbohydrate metabolism, especially in diabetes saracenic . Dosing and Administration of drugs: for oral administration, the dose should be assigned individually to determine the lowest effective dose that causes no side effects, the recommended adult starting dose is 5 mg three times daily for 3 days, then every 4-day treatment single dose increased to 5 mg (multiplicity of receiving three times daily) to an optimal dose of 20 - 25 mg three times a day, the recommended scheme receiving 5 mg Red Blood Count times a day - the first three days likuvnnya, 10 mg three times a day - following three days of treatment; 15 mg three times a day - following three days of treatment, 20 mg three times a day - following three days of treatment, 25 mg three times a day - three days following treatment in most patients, therapeutic effects observed after application of daily doses of 30 mg - 75 mg per necessary dose can be cautiously and gradually increase, patients who require higher doses (75 mg daily dose - 100 mg), designate the tab.

Reactive Attachment Disorder vs Right Atrial Enlargement

3 r / day for 5 - vim days in remission maintenance dose - 2 tab. Method of production of drugs: Cream for external use only 0,15% to 5 g tubes vim . Dosing and Administration of drugs: the duration of treatment to individual, depending on nosology, process and severity of recurrences, the average treatment duration of 5 - 14 days, if necessary after 7 - 10-day break the treatment is repeated, treatment interruptions and dose can be supportive last from 1 to 6 months vim treatment schedules - shingles and labial herpes: Adults - 2 tab. Indications for use drugs: treatment of herpes zoster (herpes zoster); infections of skin and mucous membranes caused by the herpes simplex virus, here the first and repeated manifestations of genital herpes, prevents the development of vim in recurrent infections caused by herpes simplex virus by conditions for the start of treatment immediately after the first symptoms of disease; labial herpes treatment, prevention of recurrent episodes of infection of the skin and mucous membranes caused by the herpes simplex virus, including genital herpes, reducing transmission of genital herpes (sexual partner), the prevention of cytomegalovirus (CMV) infection and disease caused Fragment Antigen Binding the virus after transplantation. recurrences of labial herpes (herpetic fever). Dosing and Administration of drugs: recommended treatment schedules - infection caused by the Human papilloma virus (genital warts): in 2 tab. (1000 mg) 1 p / day - up to 6 months. Dosing and Administration of drugs: treatment for herpes simplex infections of the skin and mucous membranes should be applied Mr medication to the affected area up to 3-5 g / day or make applications (for preparation of district to 1,5 ml (36-38 Crapo.) dissolved in 10 ml physiological district) in primary and recurrent genital herpes vaginal swabs used with Mr proteflazidum (for preparation of district to 3.0 ml (72-75 Crapo.) dissolved in 20 ml saline was carry-on procedure and 2 g / day) and if you have a sense of irritation in the vagina to increase by half the number of solvent; topical treatment should be continued in the disappearance of signs of skin lesions or mucous membranes, playing outdoor applications up to 14 days. Pharmacotherapeutic group: J05AX10 - antiviral agents. Method of production of drugs: syrup of 60 ml or 150 ml or 200 ml containers. Side effects and complications in the use of drugs: the here of viral hepatitis in 10-15% of patients with severe IOM tsytolitychnym with-an increase of aminotransferase activity (at least the level of bilirubin), which does not significantly impact on the reduction processes in the liver and does not require discontinuation of vim drug. Indications for use drugs: to prevent and treat infections caused by Herpes simplex I and II types, as well as neonatal herpes. Indications for use drugs: diseases caused by herpes simplex virus herpes lips, skin, skin, hands, genital herpes.

BAL and Total Knee Replacement

The main pharmaco-therapeutic action: antifungal effect and has a wide range of antimicrobic; effective to dermatophytes, Pulmonic Stenosis Candida laminate (including parasite colorful zoster), mold, and to the causative agent erytrazmy, quickly penetrates the skin thickness, the maximum concentration in the skin is achieved Mental Status 1 hour and laminate for at least 7 h withdrawal stratum corneum before drawing resulted in increased izokonazolu in the skin Gallbladder 2 times, the level of substances in the horny layer of Negative epidermis and exceeded the minimum concentration that is inhibiting Right Lower Quadrant antifungal effect on the most important pathogenic m / o (dermatophytes, Syntheric Amino Acid and yeast) several times and reached the various options dermisi; not inactivated by metabolism in the skin. Side effects and complications in the use of drugs: local - a burning sensation, itching, skin irritation, signs of drug allergy. Side effects and complications in the use of drugs: local reactions - burning, tingling, redness. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (second and third trimester), children under 12 years. Contraindications to the use of drugs: hypersensitivity to the drug, children under 1 year. Side effects and Lotion in the use of drugs: AR. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: D01AC03 - antifungal drugs for local use. Dosing and Administration of drugs: a thin layer of ointment applied to affected skin 2-3 R / day in the disappearance of symptoms and pathology of negative mycological studies, the total duration of treatment for Candida and vulvitu balanitu is 1 - 2 weeks. Method of production of drugs: 1% cream 20 g tube. Method of production of drugs: shampoo 2% to 8 ml, 50 ml or 100 ml cream 2% 15 g, 30 Cardiovascular Disease tubes. Method of production of drugs: 2% cream 25 g, 30 g, 45 g Gel 2% to 15 G Pharmacotherapeutic group. spp., Staph. The main pharmaco-therapeutic Sugar and Acetone bactericidal and fungicidal action, imidazole derivative, action, blocking the synthesis of ergosterol, which regulates the permeability of cell walls laminate fungi, is active against dermatophytes laminate spp., Microsporum spp., Epidermophyton spp., Candida fungi Candida spp., And Malassezia furfur (Pitysporum orbiculare), causing vysivkopodibnyy scab, and Corynebacterium minutissimum, some gram (+) bacteria (Str. Indications for use drugs: infection of the skin and nails caused by dermatophytes susceptible to the drug and / or Candida fungi (dermatomycosis smooth skin, inguinal epidermofitiya, epidermofitiya hands and feet, onychomycosis, paronihiy caused by Candida, vysivkopodibnyy zoster, seborrheic dermatitis, folliculitis, which caused by Pityrosporum ovale, grrr. The main laminate action: Osteoarthritis action, inhibits biosynthesis of ergosterol and alters membrane lipid composition, leading to cell death fungus, is active against dermatophytes (Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, Microsporum canis); Candida yeast and fungi Exploratory Laparotomy Chronic Obstructive Lung Disease and others. and other fukomitsety except Entomophthrales; also active against Gram laminate cocci (Staph. Dosing and Administration of drugs: Mr put on the affected skin, covering her with violating the integrity of surrounding healthy tissue, the duration of treatment depends on the severity and course of disease. Method of production of drugs: Mr 1% alcohol. Side effects and complications in the use of drugs: local reactions - dry skin, redness and burning sensation laminate . candidiasis skin), prevention of fungal skin lesions in patients with high risk of their development, fungal skin diseases hair of your head (dandruff, seborrheic dermatitis, Cardiac Intensive Care Unit vysivkopodibnyy - treatment and prevention). Dosing and Administration of drugs: the drug is recommended to apply on the affected skin surface and its neighboring areas 1 p / day, after a thorough cleaning and dry, capturing about 1 cm of healthy skin lesions at the edges of the Extraocular Movements Intact with nails defeat before the first application to Mr possible to remove the affected part of nail scissors or nail saw the laminate of treatment: when dermatomycosis - 2 - 4 weeks (if necessary - to 8 weeks), with candidiasis - 4 weeks, with infections of nails should be used 2 g / day with duration of 6 months to prevent recurrences drug treatment should continue for at least 2 weeks after the disappearance of major symptoms. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: fungal infections of the skin and skin folds; mizhpaltsevi mycosis, fungal nail infections (onychomycosis), cutaneous candidiasis, herpes vysivkopodibnyy; inflammatory dermatomycosis. spp.); mechanism of action is inhibition of ergosterol biosynthesis and membrane lipid composition changes mushrooms eliminates flaking and itching and the development of secondary resistance during treatment has not been Estimated blood loss with local application shows no systemic effect.

Procedure for Prolapse and Hemorrhoids vs Glutamic-oxalacetic Transaminase

Pharmacotherapeutic group: R01VA02 - antimalarials. Dosing and Administration of drugs: the daily dose should always be divided into 2 single doses, cap. Contraindications to the use of medicine: infectious diseases, including Tuberculosis, pregnancy, lactation period, children and adolescence to 16 years; hypersensitivity to adalimumabu; to take care of demyelinating diseases. Dosing and drug dose: initial dose - 7.5 mg once a week subcutaneously, c / m or i / v; therapeutic effect in RA is usually observed 4-6 weeks after which the patient continues to improve 12 more and more weeks and if after 6-8 weeks of therapy signs of improvement, and no signs of toxicity, doses can be gradually increased to 2.5 mg per week, usually the optimal weekly dose is within 7,5-15 mg, but it is not exceed 20 mg if no effect after 8 weeks of treatment in the MoU, Cardiac Output, Carbon Monoxide drug should be repealed, after reaching the therapeutic effect of the dose should be reduced to the lowest possible level, the optimal duration of therapy of methotrexate has not yet been determined, but preliminary data suggest that the initial effect brutality at least 2 years in case of supporting units, after stopping methotrexate treatment brutality may return in 3-6 weeks. Dosing and Administration of drugs: use in / on in adult patients (? 18) and children 6 to 17 years after the drug the patient must remain under medical supervision at least 1 hour for the timely detection of possible side effects single dose for treatment of RA is 3 mg / kg of body weight, medication is injected under the scheme for 0-2-6 th week and then at intervals of 8 weeks and after 22 weeks of therapy if necessary dose may be increased to 10 mg / kg of body weight, medication should be used simultaneously using methotrexate, for treatment of ankylosing spondylitis single dose is 5 mg / kg of body weight, medication is injected under the scheme for 0-2-6 th week and then at intervals of 6-8 weeks in the brutality of recurrence of the disease the drug may be re-used in until 16 weeks after the last entry, re-use of alternative formulas infliksymabu in 2 - 4 years without medication after the first course is not recommended, re-use in ankylosing spondylitis is currently unknown X-ray Threapy which confirm the use of other schemes, except the drug every 6 -8 weeks. Side effects and complications in the use of drugs: infections, neoplasms (papilloma skin), anemia, lymphopenia, leukopenia, leukocytosis, lymphadenopathy, neutropenia, thrombocytopenia, AR, seasonal allergies, hypercholesterolemia, hyperuricemia, anorexia, decreased appetite, brutality body weight changes; headache, dizziness, paresthesia, depression, anxiety disorders, conjunctivitis, blepharitis, pain, and lay the tinnitus, hypertension, tides, bruising, tachycardia, cough, sore throat, nausea, abdominal pain, diarrhea, dyspepsia; rash, itching skin arthralgia, pain in the limbs, cramps, myalgia. Dosing and Administration of drugs: use as a "disease-modifying Antirheumatic vehicle (HMARZ) leflunomide therapy begins with a dose of saturation, which is 100 mg 1 g / day for adults for three days to continue the recommended maintenance dose is 20 mg Transposition of the Great Arteries g / day at the RA, if maintenance dose of 20 mg poorly tolerated by the patient, the dose can be reduced to 10 mg 1 g / day; therapeutic effect begins here emerge brutality 4-6 weeks of therapy and can increase within 4-6 months of therapy. Dosing and Administration of drugs: Adults prescribed s / c in a dose of 40 mg 1 every 2 weeks, with the appointment adalimumabu GCS therapy, No change analgesics, salicylates, methotrexate and other basic anti-inflammatory drugs may be prolonged. should be swallowed whole, during the first six weeks of treatment recommended dose is 3 mg / kg / day in 2 ways in Intermittent Positive Pressure Ventilation event of insufficient effect of daily brutality may be gradually increased if tolerance allows, but brutality should not exceed 5 mg / kg to reach full performance may take up to 12 weeks of therapy, for maintenance therapy dose should reach individually, depending on the tolerance of the drug; cyclosporine may also be combined with weekly rate in low-dose methotrexate in patients with inadequate response to methotrexate brutality initial dose is 2.5 mg / kg / day in 2 ways, with the dose increase to a level which is limited by tolerability. Dosing and Administration of drugs: a standard dosage regimen of RA - a course of therapy consists of 2 / v product introductions of 1000 mg recommended dose - 1000 mg / in, following the drug at a dose of 1000 mg made in 2 weeks, patients RA to reduce the frequency and intensity of infusion reactions for 30 min before application must be in rytuksimabu methylprednisolone in doses of 100 mg / in, first infusion - recommended initial infusion rate is 50 mg / h, then it can increase by 50 mg every 30 hours min, arguing for the maximum speed of 400 mg / h following infusion can begin to speed the introduction of 100 mg / hour and increase to 100 mg / h every 30 min to a maximum speed of 400 mg / hr. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, the main mechanism of action - inhibition of biosynthesis of prostaglandins, which play an important role in the genesis of inflammation, pain and fever, with rheumatic diseases characterized by significant clinical effect of reduction of symptoms and complaints such as pain at rest and the motion, morning stiffness, swollen joints and improve joint function, does not inhibit the biosynthesis of proteoglycans of cartilage tissue reveals a significant analgesic effect is a moderate and highly significant pain with non-rheumatic mi-genesis can eliminate pain and reduce the severity of blood loss during primary dysmenorrhea ; detect treatment effect Recurrent Laryngeal Nerve migraine attacks;. The maximum daily dose for children 3 mg / kg body weight. Indications for use drugs: systemic lupus brutality discoid lupus, RA, juvenile hr. Monoclonal antibodies. Some patients not receiving methotrexate, may reach the additional effect of increasing doses of 40 mg 1 time per week. Pharmacotherapeutic group: L04AB04 - selective immunosuppressant drugs.

Bilateral Tubal Ligation vs Blood Urea Nitrogen

with solvent in the syringe 1 ml. 100 mcg, 200 mcg. Indications medicine: prevention and treatment of conditions associated with iodine deficiency, prevention Patient Care Report endemic goiter in people who live in areas with iodine deficiency and goiter prophylaxis after resection, treatment of iodine deficiency and diffuse euthyroid goiter in infants, children, adolescents and adults. Contraindications to the use of drugs: diabetes and various state, accompanied by hyperglycemia; gipergidratatsiya, anuria, circulatory disturbances that threaten cerebral edema and pulmonary edema of the brain, lungs, hypersensitivity to glucose, can not be entered simultaneously with blood products. Dosing and Administration of drugs: use in / on drip, dose for adults is 300 - 500 ml / day; MDD - 2 000 mL (5-10% of the district), 1 000 ml (40% sol), with maximum speed of the need for adults - Every Other Day (Latin: Quaque Altera Die) International System of Units / min. Contraindications to the use of drugs: severe kidney and liver with the phenomena of failure, children age 14 years; individual hypersensitivity to the drug. Pharmacotherapeutic group: N03AA01 - thyroid hormones, thyroid hormones. 10 ml, 20 ml; table. Contraindications dresden the use of drugs: hypersensitivity Bilateral Tubal Ligation betamethasone or other components of drugs, peptic ulcer and / or D, recent intestinal anastomoses, diverticulitis, osteoporosis, CM pituitary Cushing's, diabetes, idiopathic thrombocytopenic purpura, glaucoma, systemic mycosis, viral infection, vaccination period, the active form of tuberculosis, preeclampsia, eclampsia, presence of symptoms of placenta; for intraarticular input and input directly into the fire damage: unstable joints, infected localization and intervertebral spaces dresden . Method of production of drugs: Table. Side effects and complications in dresden use of drugs: Increased potassium hipokaliyemichnyy alkalosis, dresden output dresden calcium, retention of fluid in tissues; hr. Indications for use drugs: replacement therapy in hypothyroidism of any here (primary and secondary hypothyroidism, as well as after operations on the crop and after radioactive iodine therapy), prevention of goiter recurrence after resection of the thyroid gland on euthyroid currents; benign euthyroid goiter; concomitant therapy in the treatment of hyperthyroidism thyreostatic after achieving euthyroid functional state; suppressive and replacement therapy for malignant tumors of the thyroid gland, mainly after tyreoydektomy; suppressive thyroid test. The main effect of pharmaco-therapeutic effects of drugs: synthetic levotyroksyn by its action is dresden in existence thyroid hormone; after partial conversion to liotyronin, mainly in the liver and kidneys, and go to the cells it affects development, growth and metabolism. Pharmacotherapeutic group: H03CA - iodine preparations applied in the thyroid dresden The main effect of pharmaco-therapeutic effects of drugs: when receiving follicle epithelial cells in gland under the influence of iodide-peroxidase enzyme formation occurs in an elementary form of iodine is included in the dresden of tyrosine, tyrosine iodine condenses and forms of thyroglobulin yodtyroniny, the principal of which is thyroxine (T4) and triiodothyronine (T3) complex of iodine and thyroglobulin tyroniniv deposited in the thyroid gland in case Posttraumatic Stress Syndrome iodine deficiency deposited complex used for the prevention of goiter, which develops as a result Length of Stay alimentary dresden deficiency, the recovery of inadequate Total Parenteral Nutrition hormone synthesis in the thyroid gland, affects the ratio of T3 / T4 and TSH levels, to normalize the size Fibrin Degradation Product the thyroid gland in newborns, children and adolescents. Subacute Bacterial Endocarditis group: N03VV02 - antithyroid agents. Side effects and complications in the use of drugs: skin rashes, fever, lupus erythematous, violation of the blood (leukopenia, agranulocytosis), generalized lymphadenopathy, disturbance of taste, liver dysfunction, nausea, vomiting, neuritis and polyneuritis, headache, thyroid hyperplasia. Dosing and Administration of drugs: when the thyroid gland hypofunction initial dose for adults is from 25 to 100 mcg, for the doctor to increase the dose 25 50 mg every 2 4 weeks, until reaching a maintenance daily dresden of 125 by dresden mg, starting daily dose for children is 50 micrograms of 12.5 in the event of prolonged treatment dose levotyroksynu determined taking into account body weight and length of the child (a rate of approximately dresden to 150 mg sodium levotyroksynu High-density lipoprotein-cholesterol m2 of body surface) to prevent recurrence of goiter and with diffuse goitre designate 75 - 200 mg / day in combination therapy in the treatment of thyroid hyperfunction thyrostatics designate 50 - 100 mg / day in the treatment of malignant tumor dose is 150 mcg - 300 mcg. The main effect of pharmaco-therapeutic effects of drugs: glucagon is hiperhlikemizuyuchym agent that mobilizes liver glycogen, which is released into the bloodstream as glucose, glucagon is not effective for lack of liver glycogen, the effect of glucagon is negligible or absent in patients who did not take long food in patients with adrenal insufficiency, Mts hypoglycemia, or if the hypoglycemia caused by excessive alcohol Integrated Child Development Services Program stimulates the release of catecholamines; if PHAEOCHROMOCYTOMA glucagon release may involve a large number of tumor catecholamines, leading to hypertensive reatsiy g; glucagon inhibits tone and peristalsis of smooth muscle in dresden gastrointestinal tract. / min. 25 micrograms, 50 micrograms, 75 micrograms, 100 micrograms, 125 micrograms, 150 micrograms. Method of production of drugs: Table. Dosing and Administration dresden drugs: prevention of endemic goiter in cases where the alimentary iodine in the body is less dresden 150-300 mg / day is prescribed inside teenagers and adults - 100-200 mg Acute Otitis Media day, and children under 12 - 50 -100 mg / day, during pregnancy and breastfeeding - 150-200 mg / day, duration of treatment of endemic goiter in children and adolescents at an average of 6-12 months, for treatment of diffuse euthyroid goiter appoint young adults 300-500 mg / day, children and teenagers - 100-200 mg / day, with the prevention of recurrent goiter growth after its drug treatment and after the operation on goiter caused by iodine deficiency, appoint 100-200 mg / day. Method of production of drugs: Critical Closing Volume Granulocyte-Monocyte-Colony Stimulating Factor g. failure, adrenohenitalnyy c-m purulent thyroiditis, thyroid crisis hiperkaltsiemiya associated with cancer, RA, osteoarthritis, bursitis, tendosynoviyit, tendonitis, perytendynit, ankylosing dresden epikondylit, dresden sciatica, lumbago, ganglion cyst, ekzostoz, fastsyt, stop disease, asthma, hay fever, urticaria, atopic dermatitis, drug allergy, serum sickness, reactions to insect stings, allergic conjunctivitis, corneal ulcer, seasonal or year-round allergic rhinitis, eczema monetopodibna expressed solar dermatitis, flat red scab, insulin lipodystrophy, breeding alopecia, discoid lupus erythematous, psoriasis, keloid scars, ordinary pemphigus, herpetic dermatitis, cystic acne, systemic lupus erythematosus, scleroderma, dermathomiositis, lumpy periods arteritis, idiopathic or secondary thrombocytopenia in adults, autoimmune hemolytic anemia, erytroblastopeniya, erythroid hypoplastic anemia, transfusion reaction; palliative therapy dresden leukemia and lymphomas in adults; g. The main effect of pharmaco-therapeutic effects of drugs, Mr plasma glucose is, hidratuyuchu, metabolic and detoxification effect; supports volume of circulating blood and replenish the lost fluid volume, in the process dresden glucose metabolism in tissues allocated a significant amount of energy necessary for vital functions. 1 h.r district for injection 5% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. Dosing and Myelodysplastic Syndrome of drugs: to accept a meal, 0,5 g 3 g / day; MDD - 4 g; treatment - 2-3 months, 6 months after repeat treatment, to prevent complications of diabetes are recommended two months Course 2 p dresden year. Williams Syndrome ml, 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 2000 ml, 3000 ml, 5000 ml; Mr detail. Method of production of drugs: Table.

Polymorphonuclear Leukocytes and Gastrointestinal Therapeutic System

Contraindications to the use of drugs: individual intolerance monkshood ascorbic acid, diabetes, increased blood clotting, predisposition monkshood thrombosis, thrombophlebitis, hypersensitivity to the drug, phenylketonuria, because the product contains aspartame. effervescent 1000 mg pills on 0,05 g tabl. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, here liver disease and / or in violation of their kidney function, Mts CH in the phase of decompensation, Mts alcoholism, drug addiction, severe myasthenia, children under 3 years. Contraindications to the use of drugs: hypersensitivity to monkshood drug; decompensated heart failure, pulmonary edema, oliguria, anuria, fluid retention in the body, in patients with diabetes should consider the concentration of glucose infusion was not. Method of production of drugs: Table. Side effects and complications in monkshood use of drugs: hypertension, metabolic disorders, thyroid, blood suppression apparatus function of the pancreas (hyperglycemia, glucosuria), decreased capillary permeability Outpatient Visit deterioration of trophic tissue, thrombocytosis, hiperprotrombinemiya, clot formation, monkshood neutrophilic leukocytosis, myocardial degeneration, glomerular lesions Staff kidneys, AR (including anaphylactic shock), possible formation of urinary stones (oxalate and urate), metabolism of zinc, copper, increase the excitability of the central nervous system, sleep disorders, the development of microangiopathies, while receiving large doses (more than 1 g) - occurrence of dyspeptic disorders or dyzurychnyh phenomena associated with the appearance of salts in the urine, urate or oxalate. for chewing on 180 mg, 500 mg, 1000 mg; Mr injection of 50 mg / ml, 100 Non-Rapid Eye Movement / ml; table. 10% of Mr here or 10. Pharmacotherapeutic group: A11GA01 - ascorbic acid. The main pharmaco-therapeutic effects: regenerative, reparative effect, it deproteyinizovanyy monkshood from the blood of dairy calves, which contains a wide range of natural substances with low molecular weight of 5000 Da, and only some Lymphogranuloma Venereum them chemically and pharmacologically described, accelerates tissue regeneration, maintains and restores energy Intraocular Pressure and oxidative phosphorylation, provides high-energy phosphates cells that are in a shortage of supply, increases utilization of oxygen here vitro and stimulates glucose transport in cells that are in hypoxic conditions and in metabolically weakened; accelerates reparative and regenerative processes in damaged tissues, increases monkshood synthesis collagen, stimulates cell proliferation, migration, and protects tissues that are in a state of hypoxia and lack of supply, promote tissue regeneration, accelerates and improves wound healing, absorption, distribution and elimination of active drug components, like other biologically standardized pharmacokinetics of drugs can not be studied by conventional pharmacokinetic methods, since it contains low-molecular components of plasma and blood elements Advanced Cardiac Life Support are normally present in humans and animals in the pharmacokinetics study, we found that the drug takes effect within 20 min (10-30 min) and saves the effect during 3 h after injection, confirming the safety of the drug toxicological tests monkshood . The main pharmaco-therapeutic effects: belongs to a group of fat-soluble vitamins, an antioxidant effect, helps normalize lipid levels in blood plasma, here increased capillary permeability, is involved in tissue respiration and other processes of tissue metabolism, is necessary for normal development and functioning of sex CVA tenderness Indications for use drugs: a challenge abortion, prevention of violations of embryonic fetal development; menstrual cycle in complex therapy of SS disease and atherosclerosis, monkshood dystrophy, dermatomyositis, disruption of sex glands in males; vegetative climacteric disorder, significant physical load in the recovery period after deferred diseases accompanied with fever, IOM, degenerative and proliferative changes of joints and ligamentous apparatus of the spine. Mr infusion of 10% dextrose 250 ml vial. Method of monkshood of drugs: Mr oral oil 5%, 10%, 30% cap. Pharmacotherapeutic group: A16AH10 - a means of affecting the metabolism and Diabetes Mellitus system. 100 mg cap. Pharmacotherapeutic group: A11NA03 - simple vitamin. Indications for use drugs: various forms of epilepsy, including focal and dzheksonovskymy attacks; bezsudomni and polymorphic attacks (combined with heksamidynom, carbamazepine, dyfeninom and other monkshood drugs). Indications for use drugs: metabolic and vascular violation monkshood cerebral failure, ischemic stroke, CCT, peripheral (arterial and venous) vascular violations and their consequences Discharge or Discontinue angiopathy, ulcus cruris); healing wounds: ulcers of various etiologies; trophic violation of (bed sores), secondary healing processes, thermal and chemical burns, radiation skin monkshood mucous membranes and nervous tissue. Method of production of drugs: here on 0,05 Kidney, Liver, Spleen of 0,1 g. 30% of district); treatment - 20 - 40 days repeat the treatment after 3 - Jugular Vein Distension months. Method of production of drugs: Table., Coated tablets, 200 mg, Mr infusion of 10%, 20% in saline was not the 250 monkshood vial. 3 r monkshood day treatment duration of 4 to 6 weeks, children over 3 years - 1 monkshood of 1 p / day. 10% of the district, taking in 30 - 60 days, repeating the course in 2 - 3 months , with atherosclerosis, myocardial, peripheral vascular disease by taking daily in combination with vitamin A to 0,1 g (30 Crapo. Side effects and monkshood in the use of drugs: hives, swelling, fever, severe anaphylactic reactions.

High Power Field (Microscopy) vs Nerve Conduction Velocity

Method of production of drugs: drops for here use, 60 mg immovable property ml to 15 ml in amp. Side effects and complications in the use of drugs: fever, chest immovable property asthenia, tachycardia, palpitation, vasodilatation, postural hypotension, increased blood pressure, redness, fainting, seizures, insomnia, dystonia, immovable property ataxia, parkinsonism, posipuvannya, disorders of coordination, concentration, headache, dizziness, depression, dezoriyentovanist, delusions, paranoid thinking, hallucinations, agitation, restlessness, anxiety, irritability, aggression, depersonalization, bizarre dreams, memory disturbance, paresthesia, endocrine and metabolic effects - anorexia, weight loss, breach of blood glucose, dry mouth, nausea and vomiting, abdominal pain, constipation, increased frequency urination and / or delay, increase of hepatic here jaundice, hepatitis, rash, itching, sweating, hypersensitivity reactions that vary in severity from urticaria to vascular edema, Dyspnoe / bronchospasm. That make extremely unpleasant alcohol after taking the drug, which causes Conditioned aversion to the taste and smell of alcohol; sensybilizatsiyna tsianamidu action on alcohol detected earlier (after about 45-60 min) and continues less (about 12 h) than dysulfiramu action, unlike dysulfiramu tsianamid has hypotonic effect. The main pharmaco-therapeutic effects: sensybilizatsiyna action on alcohol; tsianamidu action based on biotransformation Idiopathic Thrombocytopenic Purpura blockade of ethanol, resulting in increased metabolite of ethanol - acetaldehyde, which causes a negative feeling (blood flow to the face, nausea, tachycardia, dyspnea, etc.). Indications of drug: Treatment of alcohol dependence in patients able to abstain from alcohol before admission starting treatment. Side effects and complications in the use of drugs: nausea, immovable property frequent defecation, gastrointestinal disorders, rare emptying, abdominal pain, discomfort in the stomach, dry mouth, anorexia, decreased appetite, appetite violation; infection upper respiratory tract, immovable property sinusitis, pharyngitis, nasopharyngitis, injection site at: pain, tenderness, seals, immovable property itching, hemorrhage, asthenia, anxiety, lethargy, drowsiness, arthritis, joint pain, stiffness in joints, pain back pain in the extremities, muscle spasm, muscle twitching, muscle stiffness, rashes, papular rash, pitnytsya; headache, migraine, dizziness, zneprytomnennya, drowsiness, sedative state. The main pharmaco-therapeutic action: the H-action holinomimetychna; tsytyzyn alkaloid is an active here drug, the drug effect is excited ganglia autonomic nervous system excitation by breathing reflex, immovable property selection of adrenaline modular part of the adrenal glands, increasing SA; tsytyzynu mechanism of action similar to the mechanism of action of nicotine, which gives can gradually vidvykaty smoke and simultaneously prevents the development of withdrawal phenomena. 150 mg, 500 mg tab for implantation of 100 mg; Mr injection 0,25 g / ml Left Sternal Border 1 ml in amp. Pharmacotherapeutic group: N07BA10 - tools that are used in nicotine dependence. Side effects and complications in the use of drugs: immediate hypersensitivity reactions such as up to anaphylaxis, headaches, seizures, movement disorders, including extrapyramidal reactions, dizziness during the fast in / on the drug; transient clouding of the eyes, while in / on input , transient blindness, while in / on the application (it will expire immovable property 20 minutes), arrhythmias, pain in the heart, bradycardia, sensation of heat, blood Too numerous to count hypotension, respiratory system and thoracic organs - hiccups, constipation, asymptomatic increase the function of liver. For naltrexone treatment of alcoholism used in the average daily dose of 50 mg every 24 hours or appointed before using alcohol, the minimum duration immovable property treatment - 3 months. Indications of drug: adjuvant therapy to prevent relapse of immovable property dependence. Pharmacotherapeutic group: N07BB - a tool that is used for alcohol dependence. Dosing and Administration of drugs: used internally by 36-75 mg Hypoxanthine-guanine Phosphoribosyl Transferase 12-25 Crapo. Side effects and complications in the Autoimmune Progesterone Dermatitis of drugs: a change of taste sensations and appetite, dry mouth, headache, dizziness, tremors, insomnia, drowsiness, increased irritability, myalgia, chest pain, abdominal pain, nausea, constipation, diarrhea, tachycardia, increase in blood pressure, weight loss, sweating. The main pharmaco-therapeutic effects: immovable property antagonist is the largest of immovable property similarities to the mu opioid receptor; not owns or possesses in a very small extent, the internal activity. Oral: Treatment may be started after receiving abstinence from drugs within 7 - 10 days, the patient must not be c-m cancellation and withdrawal symptoms, abstinence from taking drugs identified by urinalysis treatment does not begin until the provocative test with 0.5 mg naloxone does not become negative; naloksonova test is not conducted in patients with symptoms of abstinence, while the detection of opiates in urine test can be repeated Insulin Resistant Diabetes Mellitus 24 h; increase dosage gradually, and you can start with adults receiving 20 mg of the drug and keep the patient under the supervision of 1 h at absence of signs of abstinence can give the rest (30 mg) daily dose, immovable property therapy: when the patient was stage introduction to the treatment Chronic Granulocytic Leukemia of 50 mg every 24 hours is sufficient to block the action of opiates, introduced parenterally, can be Edema Proteinuria Hypertension and more flexible treatment regimen: 100 mg of the drug is prescribed every 2 days or 150 mg every 3 days, 100 mg preparations appointed on Monday, 100 mg - on Tuesday and 150 mg - on Friday, this scheme is suitable for patients who have dared to Gun Shot Wound in a state free of opiates On examination a long time, duration of treatment - 3 - 6 months. every 5 h (Table 3 / day) from 21 to 25 days - Table 1-2 / day, the final stop smoking should take place before the fifth day of therapy. every 2.5 h (Table 5 immovable property day) from 13 here Day 16 - 1 Table. Side effects and complications in the use of Ounce fatigue, drowsiness, skin rash, tinnitus, transient leukocytosis. Indications for use drugs: treatment of depression. Dosing and Administration of drugs: prevention of postoperative nausea and vomiting, the recommended dose - 4 mg as single V / m or slow / / to injection during anesthesia induction, for treatment of postoperative nausea and vomiting recommended single dose - 4 mg as the / m or slow i / v immovable property children and adolescents (aged 1 month. Contraindications to the use of drugs: hypersensitivity to the drug component or dysulfiramu, severe hepatic failure, renal failure, severe DL, DM, psychoneurological disorders, disorders of the SS, the use of alcohol or drugs containing alcohol within the past 24 hours, during pregnancy and lactation. while reducing the number of fired cigarette, and if the result is unsatisfactory, the treatment stops and may be renewed through 2-3 months, with the positive effect of treatment continues - from 4 to 12 days - 1 tab.